about
TRPV1 and SP: key elements for sepsis outcome?Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammationTargeting NK-1 Receptors to Prevent and Treat Pancreatic Cancer: a New Therapeutic ApproachCB(1) receptor antagonist SR141716A increases capsaicin-evoked release of Substance P from the adult mouse spinal cordHemodynamic effects of substance P and its receptor antagonist RP67580 in anesthetized rats with carbon tetrachloride-induced cirrhosisActivation of neurokinin-1 receptors during ozone inhalation contributes to epithelial injury and repairThe role of substance P in depression: therapeutic implications.Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathwaysSynthesis of two potential NK1-receptor ligands using [1-11C]ethyl iodide and [1-11C]propyl iodide and initial PET-imaging.Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor.Acid mediates a prolonged antinociception via substance P signaling in acid-induced chronic widespread pain.Molecular Ghrelin System in the Pancreatic Acinar Cells: The Role of the Polypeptide, Caerulein and Sensory Nerves.The Role of Substance P in Secondary Pathophysiology after Traumatic Brain Injury.Expression and function of human hemokinin-1 in human and guinea pig airwaysInvolvement of substance P and the NK-1 receptor in human pathology.The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.Bilateral increase in expression and concentration of tachykinin in a unilateral rabbit muscle overuse model that leads to myositis.A neurokinin 1 receptor antagonist decreases postoperative peritoneal adhesion formation and increases peritoneal fibrinolytic activitySubstance P differentially modulates firing rate of solitary complex (SC) neurons from control and chronic hypoxia-adapted adult ratsTachykinins and their possible modulatory role on testicular function: a review.Aprepitant--a novel NK1-receptor antagonist.Mechanisms of selection mediated by interleukin-7, the preBCR, and hemokinin-1 during B-cell development.An antinociceptive role for substance P in acid-induced chronic muscle pain.Substance P Inhibits Hyperosmotic Stress-Induced Apoptosis in Corneal Epithelial Cells through the Mechanism of Akt Activation and Reactive Oxygen Species Scavenging via the Neurokinin-1 ReceptorParacrinicity: the story of 30 years of cellular pituitary crosstalk.Inflammation in acute CNS injury: a focus on the role of substance PComparative DNA methylation among females with neurodevelopmental disorders and seizures identifies TAC1 as a MeCP2 target gene.Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.Long-range regulatory synergy is required to allow control of the TAC1 locus by MEK/ERK signalling in sensory neurones.Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout modelsFragmentation of peptide negative molecular ions induced by resonance electron capture.Neurokinins inhibit low threshold inactivating K+ currents in capsaicin responsive DRG neurons.Managing insomnia: an overview of insomnia and pharmacologic treatment strategies in use and on the horizon.Neuronal pathways linking substance P to drug addiction and stress.Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injuryDifferential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)Modulation of firing and synaptic transmission of serotonergic neurons by intrinsic G protein-coupled receptors and ion channels.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues.bHLH proneural genes as cell fate determinants of entero-endocrine cells, an evolutionarily conserved lineage sharing a common root with sensory neurons.
P2860
Q27015036-C939393D-0FA9-42E9-9F67-3C05A5FF33CDQ28069959-EDC4C116-A5B0-4564-9D6B-E9F0D6E6A3D2Q28085005-7FB9B937-8FE1-49EE-8B52-17835AD1055BQ28344830-7E290EA1-F286-4666-A9CB-338C12847A92Q28569136-C7BC069E-C102-477F-B71E-999C4AE717FCQ28582551-F64C9941-DDB3-46FD-8B9C-24098894AD74Q30473429-EFD4D4FA-B3D2-4C42-AE5E-5767C748319BQ30543898-5535F252-E7C2-4BA2-852A-D730D76489B4Q33292462-F53AC5B9-05ED-4CE4-91DA-2854AC51A492Q33558850-662A87B5-43A7-4319-B991-0FF9FF1AA507Q33690254-36265D28-9AC1-4320-BD34-7FCBC17B62D1Q33754858-FD99E07C-AF2F-43A5-A2CD-E2E42B78E3C5Q33843032-94419ED8-CC9D-4C2F-A069-4E7A5F109755Q34221590-22DBA3E6-3E5D-4A88-9C56-52BCAFE51B5AQ34413850-D42F3899-0BBF-4CF8-8530-B25F5808C8D0Q34475975-C4F107AD-1053-40A6-8A2F-CD4F5250274BQ34669439-6043D3AA-181F-4F1F-8493-8301C195D6E0Q34836509-24CFB16A-753C-4FCA-910C-1BD35EA42AF2Q35091587-85DBF695-4546-42B6-A04A-EEBB9D02F556Q35170894-D668FB4F-F267-49F5-87F2-87ABE4EA304BQ35594000-881021A9-F043-47D2-AD54-DCCE0CF1F5C5Q35666672-12599348-3500-46F0-8DB3-0EACA8CC6287Q35673827-87BD7105-AA9D-4B5B-80C9-C17770DC3AEFQ35930971-FEE7BDA2-B874-4C86-899B-13AA831EDDA0Q36435897-22997321-C50D-4C65-9807-991A7FBFE5D8Q36546990-EC1CB0E7-588D-4548-A6E4-3D71061FADDCQ36980707-871A4E31-D67C-4CF9-9A15-8240C02F18E8Q37004651-1D11F20A-73E6-43CD-A90E-832B34ACFE65Q37033102-A09C3626-8E10-4F07-973C-877F95FCAEEEQ37206280-D9A68176-306C-4D6D-B5E6-F71AC4F39865Q37315247-4C9CDBB2-47D4-4A11-B0B5-00EEC7297E01Q37417613-4A1E6A82-E9BB-4A58-9FF2-62A8E1651991Q37450164-EAFF09C1-13D1-4251-B7F3-465813E1989CQ37632838-6422A71F-FD2A-43F3-B5A9-BFEC2E3BB00AQ37686770-A1CBC965-2A15-48D9-94F2-BE268AD7BC1FQ37730595-8A0A98DB-8D12-465D-AFA0-C4C6942F8F52Q38111762-55B482F1-FFA7-4492-A075-0E249EA5A8E0Q38217456-6B754FEB-B087-410D-9A4D-89C7C0B3350CQ38391996-8B81CBB2-55A7-4CB9-844F-D37B0875AA3CQ38656701-8563DBE8-170C-479B-9BFC-BBA51BF6E186
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Substance P: a pioneer amongst neuropeptides.
@ast
Substance P: a pioneer amongst neuropeptides.
@en
type
label
Substance P: a pioneer amongst neuropeptides.
@ast
Substance P: a pioneer amongst neuropeptides.
@en
prefLabel
Substance P: a pioneer amongst neuropeptides.
@ast
Substance P: a pioneer amongst neuropeptides.
@en
P2860
P1476
Substance P: a pioneer amongst neuropeptides.
@en
P2093
P2860
P356
10.1046/J.0954-6820.2000.00773.X
P407
P577
2001-01-01T00:00:00Z